Sponsor Deadline:
Jan 26, 2024
Letter of Intent Deadline:
Sep 15, 2022
Sponsor:
Leukemia & Lymphoma Society
UI Contact:
Updated Date:
Jul 10, 2023
Through this program, LLS aims to generate new evidence that can guide policy reform and changes in healthcare practice, in order to mitigate the impact of social, economic and environmental disadvantages and reduce barriers to care. Learn about our 2023 Equity in Access Research Program grantees and their research following this year’s application information.
Opportunities:
- Building Evidence for Effective Strategies to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups
- Understanding How Health Insurance Affects Equity in Access to Care for Patients with and Survivors of Blood Cancer